Product
HS-10380
2 clinical trials
1 indication
Indication
SchizophreniaClinical trial
A Phase Ⅰb/Ⅱ, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of HS-10380 in Chinese Adults With Schizophrenia.Status: Not yet recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HS-10380 in Chinese Healthy Adult SubjectsStatus: Recruiting, Estimated PCD: 2023-06-30